Cargando…

Key changes in the future clinical application of ultra-high dose rate radiotherapy

Ultra-high dose rate radiotherapy (FLASH-RT) is an external beam radiotherapy strategy that uses an extremely high dose rate (≥40 Gy/s). Compared with conventional dose rate radiotherapy (≤0.1 Gy/s), the main advantage of FLASH-RT is that it can reduce damage of organs at risk surrounding the cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Binwei, Fan, Mi, Niu, Tingting, Liang, Yuwen, Xu, Haonan, Tang, Wenqiang, Du, Xiaobo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628486/ https://www.ncbi.nlm.nih.gov/pubmed/37941555 http://dx.doi.org/10.3389/fonc.2023.1244488

Ejemplares similares

FLASH Radiotherapy: History and Future
por: Lin, Binwei, et al.
Publicado: (2021)

Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?
por: Wilson, Joseph D., et al.
Publicado: (2020)

Corrigendum: Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?
por: Wilson, Joseph D., et al.
Publicado: (2020)

Research progress on the mechanism of radiation enteritis
por: Fan, Jinjia, et al.
Publicado: (2022)

Non-conventional Ultra-High Dose Rate (FLASH) Microbeam Radiotherapy Provides Superior Normal Tissue Sparing in Rat Lung Compared to Non-conventional Ultra-High Dose Rate (FLASH) Radiotherapy
por: Wright, Michael D, et al.
Publicado: (2021)

Low radiotherapy dose is suitable for brain metastases in SCLC compared with high dose
por: Xu, Liming, et al.
Publicado: (2023)

Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac
por: Gao, Lin-Rui, et al.
Publicado: (2023)

Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer
por: Wang, Bin, et al.
Publicado: (2022)

Radioimmunotherapy Combined With Low-Intensity Ultrasound and Microbubbles: A Potential Novel Strategy for Treatment of Solid Tumors
por: Lin, Binwei, et al.
Publicado: (2021)

Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated Boost
por: van Schie, Marcel A., et al.
Publicado: (2019)

FLASH Radiotherapy Using Single-Energy Proton PBS Transmission Beams for Hypofractionation Liver Cancer: Dose and Dose Rate Quantification
por: Wei, Shouyi, et al.
Publicado: (2022)

Low-Dose Radiotherapy Versus Moderate-Dose Radiotherapy for the Treatment of Indolent Orbital Adnexal Lymphomas
por: Baron, Jonathan, et al.
Publicado: (2021)

Predicting the efficacy of radiotherapy for esophageal squamous cell carcinoma based on enhanced computed tomography radiomics and combined models
por: Liu, Jihui, et al.
Publicado: (2023)

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
por: He, Jiaoxue, et al.
Publicado: (2023)

Mechanisms of FLASH effect
por: Lin, Binwei, et al.
Publicado: (2022)

Tangential Field Radiotherapy for Breast Cancer—The Dose to the Heart and Heart Subvolumes: What Structures Must Be Contoured in Future Clinical Trials?
por: Duma, Marciana Nona, et al.
Publicado: (2017)

Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation
por: Hellevik, Turid, et al.
Publicado: (2014)

Whole-Brain Radiation Therapy With Simultaneous Integrated Boost Versus Whole-Brain Radiation Therapy Plus Stereotactic Radiosurgery for the Treatment of Brain Metastasis From Lung Cancer
por: Lin, Binwei, et al.
Publicado: (2021)

Study of peripheral dose from low-dose CT to adaptive radiotherapy of postoperative prostate cancer
por: Gan, Guanghui, et al.
Publicado: (2023)

Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy
por: Yang, Ying-Chieh, et al.
Publicado: (2016)

Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy
por: Meng, Yinnan, et al.
Publicado: (2020)

A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome
por: Ryg, Una, et al.
Publicado: (2022)

Visualized Analysis of Heavy Ion Radiotherapy: Development, Barriers and Future Directions
por: Jin, Yuanchang, et al.
Publicado: (2021)

Correlation Between Lung Density Changes Under Different Dose Gradients and Radiation Pneumonitis—Based on an Analysis of Computed Tomography Scans During Esophageal Cancer Radiotherapy
por: Du, Feng, et al.
Publicado: (2021)

Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastoma
por: Amidon, Ryan F., et al.
Publicado: (2022)

Ultra-Low-Dose Radiotherapy for Palliation of Mycosis Fungoides
por: Aral, İpek Pınar, et al.
Publicado: (2020)

Corrigendum: Correlation Between Lung Density Changes Under Different Dose Gradients and Radiation Pneumonitis—Based on an Analysis of Computed Tomography Scans During Esophageal Cancer Radiotherapy
por: Du, Feng, et al.
Publicado: (2021)

Esophageal Cancer Radiotherapy Dose Escalation Meta Regression Commentary: “High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis”
por: Chow, Ronald, et al.
Publicado: (2021)

Combination of 35-Gene Mutation Profile and Radiotherapy Dosimetry Predicts the Therapeutic Outcome of Definitive Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma
por: Tang, Peng, et al.
Publicado: (2021)

Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy?
por: Champion, Ambroise, et al.
Publicado: (2023)

Efficacy and safety of different radiotherapy doses in neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: A retrospective study
por: Xu, Yuyan, et al.
Publicado: (2023)

Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy Versus Conventional Salvage Radiotherapy for Patients With Recurrent Prostate Cancer
por: Vogel, Marco M. E., et al.
Publicado: (2021)

Online daily assessment of dose change in head and neck radiotherapy without dose‐recalculation
por: Vickress, Jason R., et al.
Publicado: (2018)

Editorial: Interaction Between Modern Radiotherapy and Novel Drugs in Prostate Cancer: Future Perspectives
por: Detti, Beatrice, et al.
Publicado: (2022)

Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer Patients
por: Cailleteau, Axel, et al.
Publicado: (2021)

A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2019)

Radiotherapy Dosing for Locally Advanced Non-Small Cell Lung Carcinoma: “MTD” or “ALARA”?
por: Ohri, Nitin
Publicado: (2017)

Impact of Magnetic Field on Dose Distribution in MR-Guided Radiotherapy of Head and Neck Cancer
por: Xia, Wenlong, et al.
Publicado: (2020)

Skin Dose Reduction by Layer-Stacking Irradiation in Carbon Ion Radiotherapy for Parotid Tumors
por: Kubo, Nobuteru, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3o0rt2f5jnruha3th3em2rt0jv